Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544

Molecular Immunology

Volumn 51, Issue 2, 2012, Pages 159-168

  Goel, Divya ^a   Bhatnagar, Rakesh ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Brucella; Intradermal; Intraperitoneal; Omp25; Th1 response; Th2 response

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; INTERLEUKIN 12; INTERLEUKIN 4; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 25; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; BRUCELLA ABORTUS; BRUCELLOSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SPLEEN; SPLEEN CELL; TH2 CELL; WESTERN BLOTTING;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BRUCELLA ABORTUS; BRUCELLA VACCINE; BRUCELLOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INJECTIONS, INTRADERMAL; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS;

EID: 84860370857     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.02.126     Document Type: Article

References (39)

1. Baldwin C.L., Goenka R. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?. Crit. Rev. Immunol. 2006, 26:407-442.
2. Barquero-Calvo E., Chaves-Olarte E., Weiss D.S., Guzman-Verri C., Chacon-Diaz C., Rucavado A., Moriyon I., Moreno E. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2007, 2:e631.
3. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., Howe B.J., Dubin G. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med. 2004, 351:2286-2294.
4. Bowden R.A., Cloeckaert A., Zygmunt M.S., Bernard S., Dubray G. Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry. Infect. Immun. 1995, 63:3945-3952.
5. Bowden R.A., Cloeckaert A., Zygmunt M.S., Dubray G. Outer-membrane protein- and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis. J. Med. Microbiol. 1995, 43:344-347.
6. Bowden R.A., Cloeckaert A., Zygmunt M.S., Dubray G. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli. J. Med. Microbiol. 1998, 47:39-48.
7. Briggs D.J., Banzhoff A., Nicolay U., Sirikwin S., Dumavibhat B., Tongswas S., Wasi C. Antibody response of patients after post exposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull. World Health Organization 2000, 78:693-698.
8. Carcaboso A.M., Hernandez R.M., Igartua M., Rosas J.E., Patarroyo M.E., Pedraz J.L. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration. Pharm. Res. 2004, 21:121-126.
9. Cloeckaert A., de Wergifosse P., Dubray G., Limet J.N. Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay. Infect. Immun. 1990, 58:3980-3987.
10. Cloeckaert A., Kerkhofs P., Limet J.N. Antibody response to Brucella outer membrane proteins in bovine brucellosis: immunoblot analysis and competitive enzyme-linked immunosorbent assay using monoclonal antibodies. J. Clin. Microbiol. 1992, 30:3168-3174.
11. Cloeckaert A., Verger J.M., Grayon M., Grepinet O. Restriction site polymorphism of the genes encoding the major 25kDa and 36kDa outer-membrane proteins of Brucella. Microbiology 1995, 141(Pt 9):2111-2121.
12. Cloeckaert A., Verger J.M., Grayon M., Vizcaino N. Molecular and immunological characterization of the major outer membrane proteins of Brucella. FEMS Microbiol. Lett. 1996, 145:1-8.
13. Cloeckaert A., Vizcaino N., Paquet J.Y., Bowden R.A., Elzer P.H. Major outer membrane proteins of Brucella spp.: past, present and future. Vet. Microbiol. 2002, 90:229-247.
14. Cloeckaert A., Zygmunt M.S., Bezard G., Dubray G. Purification and antigenic analysis of the major 25-kilodalton outer membrane protein of Brucella abortus. Res. Microbiol. 1996, 147:225-235.
15. Commander N.J., Spencer S.A., Wren B.W., MacMillan A.P. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes. Vaccine 2007, 25:43-54.
16. Edmonds M.D., Cloeckaert A., Booth N.J., Fulton W.T., Hagius S.D., Walker J.V., Elzer P.H. Attenuation of a Brucella abortus mutant lacking a major 25kDa outer membrane protein in cattle. Am. J. Vet. Res. 2001, 62:1461-1466.
17. Edmonds M.D., Cloeckaert A., Elzer P.H. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis. Vet. Microbiol. 2002, 88:205-221.
18. Edmonds M.D., Cloeckaert A., Hagius S.D., Samartino L.E., Fulton W.T., Walker J.V., Enright F.M., Booth N.J., Elzer P.H. Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant. Res. Vet. Sci. 2002, 72:235-239.
19. Godfroid J., Cloeckaert A., Liautard J.P., Kohler S., Fretin D., Walravens K., Garin-Bastuji B., Letesson J.J. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 2005, 36:313-326.
20. Gross A., Terazza A., Bettache S.O., Liautard J.P., Dornand J. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect. Immun. 1999, 68:342-351.
21. Jacques I., Cloeckaert A., Limet J.N., Dubray G. Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella. J. Med. Microbiol. 1992, 37:100-103.
22. Jubier-Maurin V., Boigegrain R.A., Cloeckaert A., Gross A., Alvarez-Martinez M.T., Terraza A., Liautard J., Kohler S., Rouot B., Dornand J., Liautard J.P. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect. Immun. 2001, 69:4823-4830.
23. Khanlou H., Sanchez S., Babaie M., Chien C., Hamwi G., Ricaurte J.C., Stein T., Bhatti L., Denouden P., Farthing C. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients. Arch. Intern. Med. 2006, 166:1417.
24. Lambert P.H., Laurent P.E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?. Vaccine 2008, 26:3197-3208.
25. Leatherbarrow R.J., Dwek R.A. Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay. Mol. Immunol. 1984, 21(4):321-327.
26. Mikszta J.A., Dekker J.P., Harvey N.G., Dean C.H., Brittingham J.M., Huang J., Sullivan V.J., Dyas B., Roy C.J., Ulrich R.G. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect. Immun. 2006, 74:6806-6810.
27. Murphy E.A., Sathiyaseelan J., Parent M.A., Zou B., Baldwin C.L. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 2001, 103:511-518.
28. Silveira S.A., Kikuchi S., Jimack L.F., Moll T., Saito T., Verbeek J.S., Botto M., Walport M.J., Caroll M., Izui S. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J. Exp. Med. 2002, 195:665-672.
29. Schurig G.G., Sriranganathan N., Corbel M.J. Brucellosis vaccines: past, present and future. Vet. Microbiol. 2002, 90:479-496.
30. + T cells. Int. Immunol. 1993, 5:877-883.
31. Taga T., Kishimoto T. Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation. Crit. Rev. Immunol. 1992, 11:265-280.
32. Verstreate D.R., Creasy M.T., Caveney N.T., Baldwin C.L., Blab M.W., Winter A.J. Outer membrane proteins of Brucella abortus: isolation and characterization. Infect. Immun. 1982, 35:979-989.
33. Weller T.H., Cheever F.S., Enders J.F. Immunologic reactions following the intradermal inoculation of influenza A and B vaccine. Proc. Soc. Exp. Biol. Med. 1948, 67:96-101.
34. Wu Y., El Shikh M.E., El Sayed R.M., Best A.M., Szakal A.K., Tew J.G. IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation. Int. Immunol. 2009, 21:745-756.
35. Yagupsky P., Baron E.J. Laboratory exposures to Brucellae and implications for bioterrorism. Emerg. Infect. Dis. 2005, 11:1180-1185.
36. Zhan Y., Cheers C. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J. Immunol. 1998, 161:1447-1453.
37. Zhan Y., Kelso A., Cheers C. Cytokine production in the murine response to Brucella infection or immunization with antigenic extracts. Immunology 1993, 80:458-464.
38. Zhan Y., Cheers C. Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro. Infect. Immun. 1995, 63:720-723.
39. Zhan Y., Liu Z., Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 1996, 64:2782-2786.